Table 1.
Main characteristics of the 58 CRBSIs and the patients.
| Characteristics | Values |
|---|---|
| Age, months, median (IQR) | 42.1 (22.8–91.83) |
| Male, n (%) | 42 (72.4) |
| Underlying condition, n (%) | |
| Hematologic tumor | 30 (51.7) |
| leukemia | 26 (44.8) |
| lymphoma | 4 (6.9) |
| Solid tumor | 19 (32.7) |
| brain tumor | 1 (1.7) |
| non-brain solid tumor | 18 (31) |
| Other hematologic conditions | 9 (15.5) |
| sickle cell disease | 4 (6.9) |
| beta-thalassemia major | 4 (6.9) |
| Langerhans histiocytosis | 1 (1.7) |
| WBC cells/mm3 median (IQR) | 2400 (400–7000) |
| Severe neutropenia, n (%) | |
| yes | 21 (36.2) |
| no | 37 (63.8) |
| Total parenteral nutrition, n (%) | 3 (5.2) |
| Type of catheter, n (%) | |
| Port-a-Cath ® | 51 (87.9) |
| Hickman ® | 7 (12.1) |
| Catheter insertion site, n (%) | |
| subclavian | 15 (25.9) |
| jugular | 8 (13.8) |
| femoral | 1 (1.7) |
| superior cava vein | 1 (1.7) |
| missing data | 33 (56.9) |
| Days from CVC insertion to infection, median (IQR) | 192 (67.5–545.5) |
CRBSIs: catheter-related bloodstream infections. IQR: interquartile range. WBC: white blood cells. CVC: central venous catheter. Severe neutropenia: <500 cells/mm3. N: 58 cases.